MRTX - Mirati Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts14131717
Avg. Estimate-3.17-3-12.26-10.27
Low Estimate-3.36-3.55-14.09-15.11
High Estimate-2.66-1.75-8.86-3.38
Year Ago EPS-3.18-3.09-13.18-12.26
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts11101616
Avg. Estimate13.43M17.66M68.97M205.82M
Low Estimate10.5M12.16M38.52M79.67M
High Estimate24.44M24.6M168M312M
Year Ago Sales5.36M1.26M12.44M68.97M
Sales Growth (year/est)150.50%1,301.60%454.60%198.40%
Earnings History6/29/20229/29/202212/30/20223/30/2023
EPS Est.-3.49-3.48-3.55-3.55
EPS Actual-3.18-3.09-3.51-3.18
Difference0.310.390.040.37
Surprise %8.90%11.20%1.10%10.40%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-3.17-3-12.26-10.27
7 Days Ago-3.17-3.03-12.31-10.3
30 Days Ago-3.44-3.33-13.52-10.94
60 Days Ago-3.44-3.32-13.51-10.96
90 Days Ago-3.44-3.33-13.66-10.95
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1414177
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRTXIndustrySector(s)S&P 500
Current Qtr.0.30%N/AN/AN/A
Next Qtr.2.90%N/AN/AN/A
Current Year7.00%N/AN/AN/A
Next Year16.20%N/AN/AN/A
Next 5 Years (per annum)-75.80%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A